ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials
Diane
The post ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials appeared first on ECOG-ACRIN Cancer Research Group .